News
TipRanks on MSN5d
Cytokinetics presents additional data related to AficamtenCytokinetics (CYTK) announced that additional data arising from two analyses from SEQUOIA-HCM, the pivotal Phase 3 clinical trial of aficamten in ...
Two New Analyses from SEQUOIA-HCM on Effect of Aficamten Between Patients with Mild and Moderate-to-Severe Symptoms, and Across Geographic Regions. HEOR Analyses of Real-World Dat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback